We typically advise that patients take semaglutide until they are able to reach their goal weight, their metabolic function has been reset, and until they have been able to establish positive changes in their diet and activity to sustain their weight loss
Clinicians can review broader guidance on GLP-1 receptor agonists through the American Diabetes Association at diabetes.org
For users experiencing dose-dependent reactions, microdosing tirzepatide offers a gentler escalation approach
Metformin (Glucophage, Glucophage XR, Fortamet) Metformin (biguanide) is the granddaddy of diabetes medications
We teach patients how to pace their doses, track symptoms, and make diet changes to achieve lasting success
Summary: Ozempic (semaglutide) is not approved or clinically proven to treat endometriosis and should not be used for this condition